Our fundraising for this ride supports the Institute of Cancer Research (ICR) in London.
We have already successfully funded 3 PhD students conducting research into secondary breast cancer, one at Imperial who has finished, one at the ICR who started in 2023 and a third who started at the ICR in 2024.
Our current campaign is for a clinical research fellow in secondary breast cancer research at the ICR. This fellowship provides the opportunity for a practising medical doctor to undertake a research degree, with the aim of developing a future leader in clinical cancer research. The cost of the fellowship (£250,000) is higher than a PhD student as it includes a clinical salary as well as tuition fees and research expenses.
Clinical research fellows play a significant role in improving outcomes for cancer patients given the two hats they wear: a practising clinician treating patients and a researcher looking into possible new treatments and detection methods. Many of the best research ideas come from clinical practice, and these research ideas in turn help inform clinical practice.
We have a JustGiving page for this ongoing campaign:
https://www.justgiving.com/campaign/onemorecity2024
(The 2024 page link remains our Just Giving Page for 2025 and beyond)
You can use this can use this page that was set up by the ICR, or set up your own page (click on ‘be a fundraiser’ on the right hand side of the page)
Given the magnitude of the fundraising we have committed to, we have decided to ask that when you book you confirm your intention to raise at least £1250 for our campaign. This is not a hard minimum fundraising requirement, but we trust that everyone will understand that we need to be focused and ambitious if we are to reach our ambitious fundraising targets. If you have any concerns about this fundraising target please speak to Christine (christine@onemorecity.cc) before you book.
Why are we fundraising for secondary breast cancer?
Much of breast cancer awareness, campaigning and research are focused around prevention and detection in the case of primary cancer, when the disease is confined to the breast and lymph nodes. Early diagnosis provides the best chance for survival, as the disease is curable in most people at this stage. However, an estimated 20-30% of primary cancers spread to other organs, which is termed secondary cancer, and at this point, the cancer is no longer curable. Those diagnosed with secondary cancer will spend the rest of their foreshortened lives on some form of treatment.
The ethos of One More City is that the journey is never over; we are always progressing towards the next city, there are always more kilometres to do, more climbs to conquer and more challenges to face. This is akin to the reality of anyone living with cancer, especially secondary cancer, for whom the challenge is never over; there are always more treatments to endure, more scans to face, more side effects to manage.
We feel strongly about focusing on research (rather than general awareness about breast cancer) and on funding a studentship (versus a piece of lab equipment for example), so that we are supporting a specific project and also contributing to the development of a scientific talent.
Monies raised by OMC are held in a ring-fenced fund until such time as a Ph.D. student can be recruited.
Any questions about fundraising please contact Nicola at the ICR.
Nicola Shaw | Senior Charity Partnerships Manager
The Institute of Cancer Research | Brookes Lawley Building | 32 Oakleaf Avenue | Belmont | Sutton | Surrey | SM2 5GP
Postal Address 123 Old Brompton Road, London, SW7 3RP
T +44 208 722 4227| E nicola.shaw@icr.ac.uk | www.icr.ac.uk | Twitter @ICR_London
Facebook www.facebook.com/theinstituteofcancerresearch
About secondary breast cancer
https://www.onemorecity.cc/why-we-ride-1
Every year around 11,500 women and 80 men die from breast cancer in the UK – that's nearly 1,000 deaths each month, 31 each day or one every 45 minutes. Breast cancer is the fourth most common cause of cancer death in the UK. Breast cancer is a leading cause of death in women under 50 in the UK.
Sadly, despite being the reason that 30% of patients with breast cancer die, secondary cancer still attracts a paucity of research funds. Most funding is poured into research projects to treat primary breast cancer or prevent breast cancer altogether.
Resources:
https://metupuk.org.uk/about-us/why-are-we-doing-this/
What is secondary breast cancer
A Pink-Ribbon Race, Years Long
This Cancer Kills 100+ People A Day
Why some cancers keep coming back
2025 Kit Available to Purchase: Rapha 2025 One More City collection